Quantitative trait locus on chromosome 20q13 for plasma levels of C-reactive protein in healthy whites: The HERITAGE Family Study

Physiological Genomics

Volumn 27, Issue 2, 2006, Pages 103-107

  Lakka, Timo A ^a,b   Rankinen, Tuomo ^f   Rice, Treva ^c   Leon, Arthur S ^d   Rao, D C ^c   Skinner, James S ^e   Bouchard, Claude ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e INDIANA UNIVERSITY   (United States)

^f Indiana University ^*

Author keywords

Genes; Genomic scan; Health, risk factors, exercise training, and genetics; Immune system; Inflammation

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME 20Q; CHROMOSOME 20Q13; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC LINKAGE; HEREDITY; HUMAN; INFLAMMATORY DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; AGE; BLOOD; BODY MASS; CANADA; CARDIOVASCULAR DISEASE; CAUCASIAN; CHROMOSOME 20; CLINICAL TRIAL; EPIDEMIOLOGY; EXERCISE; GENETIC MARKER; GENETICS; HORMONE SUBSTITUTION; INFLAMMATION; INTERVENTION STUDY; MULTICENTER STUDY; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN CONSUMPTION; QUANTITATIVE TRAIT; QUANTITATIVE TRAIT LOCUS; SIBLING; SMOKING; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; BODY MASS INDEX; C-REACTIVE PROTEIN; CANADA; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHROMOSOMES, HUMAN, PAIR 20; CONTRACEPTIVES, ORAL; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXERCISE; FEMALE; GENETIC MARKERS; HORMONE REPLACEMENT THERAPY; HUMANS; INFLAMMATION; INSULIN; INTERVENTION STUDIES; LOD SCORE; MALE; OXYGEN CONSUMPTION; QUANTITATIVE TRAIT LOCI; QUANTITATIVE TRAIT, HERITABLE; SAMPLING STUDIES; SIBLINGS; SMOKING; TRIGLYCERIDES; UNITED STATES;

EID: 34247857366     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00054.2005     Document Type: Article

References (51)

1. Abecasis GR, Cardon LR, and Cookson WO. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66: 279-292, 2000.
2. Abecasis GR, Cherny SS, Cookson WO, and Cardon LR. Merlin - rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 1: 97-101, 2002.
3. Agrawal A, Cha-Molstad H, Samols D, and Kushner I. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50. J Immunol 166: 2378-2384, 2001.
4. Bouchard C, Leon AS, Rao DC, Skinner JS, Wilmore JH, and Gagnon J. The HERITAGE family study. Aims, design, and measurement protocol. Med Sci Sports Exerc 27: 721-729, 1995.
5. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB, Akots G, Rich SS, and Freedman BI. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46: 882-886, 1997.
6. Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, Sharma P, Lowe GD, World MJ, Humphries SE, and Hingorani AD. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23: 2063-2069, 2003.
7. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH, Polak JF, Sutton-Tyrrell K, Herrington DM, Price TR, and Cushman M. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 108: 166-170, 2003.
8. Chagnon YC, Borecki IB, Perusse L, Roy S, Lacaille M, Chagnon M, Ho-Kim MA, Rice T, Province MA, Rao DC, and Bouchard C. Genome-wide search for genes related to the fat-free body mass in the Quebec family study. Metabolism 49: 203-207, 2000.
9. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, and Camaioni E. Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 21: 105-128, 2001.
10. Decker EL, Nehmann N, Kampen E, Eibel H, Zipfel PF, and Skerka C. Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression. Nucleic Acids Res 31: 911-921, 2003.
11. Deng HW, Deng H, Liu YJ, Liu YZ, Xu FH, Shen H, Conway T, Li JL, Huang QY, Davies KM, and Recker RR. A genomewide linkage scan for quantitative-trait loci for obesity phenotypes. Am J Hum Genet 70: 1138-1151, 2002.
12. Dong C, Wang S, Li WD, Li D, Zhao H, and Price RA. Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am J Hum Genet 72: 115-124, 2003.
13. Dupuis J, Larson MG, Vasan RS, Massaro JM, Wilson PW, Lipinska I, Corey D, Vita JA, Keaney JF Jr, and Benjamin EJ. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 182: 307-314, 2005.
14. Elston RC, Buxbaum S, Jacobs KB, and Olson JM. Haseman and Elston revisited. Genet Epidemiol 19: 1-17, 2000.
15. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, and Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102: 42-47, 2000.
16. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, and Sattar N. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland coronary prevention study. Diabetes 51: 1596-1600, 2002.
17. Furstenau U, Schwaninger M, Blume R, Jendrusch EM, and Knepel W. Characterization of a novel calcium response element in the glucagon gene. J Biol Chem 274: 5851-5860, 1999.
18. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD, Ally DS, Mohlke KL, Silander K, Kohtamaki K, Chines P, Balow J Jr, Birznieks G, Chang J, Eldridge W, Erdos MR, Karanjawala ZE, Knapp JI, Kudelko K, Martin C, Morales-Mena A, Musick A, Musick T, Pfahl C, Porter R, and Rayman JB. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 67: 1174-1185, 2000.
19. Horsley V and Pavlath GK. NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 156: 771-774, 2002.
20. Jacobs KB, Gray-McGuire C, Cartier KC, and Elston RC. Genome-wide linkage scan for genes affecting longitudinal trends in systolic blood pressure. BMC Genet 4, Suppl 1: S82, 2003.
21. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, and Krolewski AS. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 46: 876-881, 1997.
22. Klupa T, Malecki MT, Pezzolesi M, Ji L, Curtis S, Langefeld CD, Rich SS, Warram JH, and Krolewski AS. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q132. Diabetes 49: 2212-2216, 2000.
23. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, and Pepys MB. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992. Circulation 99: 237-242, 1999.
24. Lawrence MC, Bhatt HS, and Easom RA. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 51: 691-698, 2002.
25. Lee JH, Reed DR, Li WD, Xu W, Joo EJ, Kilker RL, Nanthakumar E, North M, Sakul H, Bell C, and Price RA. Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet 64: 196-209, 1999.
26. Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, and Bouchard C. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100: 1240-1247, 1997.
27. Luo TH, Zhao Y, Li G, Yuan WT, Zhao JJ, Chen JL, Huang W, and Luo M. A genome-wide search for type II diabetes susceptibility genes in Chinese Hans. Diabetologia 44: 501-506, 2001.
28. McCaffrey PG, Luo C, Kerppola TK, Jain J, Badalian TM, Ho AM, Burgeon E, Lane WS, Lambert JN, Curran T, Verdine GL, Rao A, and Hogan PG. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262: 750-754, 1993.
29. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, and Mullington JM. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 47: 426-430, 2001.
30. Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, Lecoeur C, Vatin V, Durand E, Hara K, Okada T, Tobe K, Boutin P, Kadowaki T, and Froguel P. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 51: 1247-1255, 2002.
31. Norman RA, Tataranni PA, Pratley R, Thompson DB, Hanson RL, Prochazka M, Baier L, Ehm MG, Sakul H, Foroud T, Garvey WT, Burns D, Knowler WC, Bennett PH, Bogardus C, and Ravussin E. Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet 62: 659-668, 1998.
32. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, and Tracy RP. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154: 681-689, 2001.
33. Peacock JM, Arnett DK, Atwood LD, Myers RH, Coon H, Rich SS, Province MA, and Heiss G. Genome scan for quantitative trait loci linked to high-density lipoprotein cholesterol: the NHLBI family heart study. Arterioscler Thromb Vasc Biol 21: 1823-1828, 2001.
34. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, and Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511, 2003.
35. Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, Meyer J, Lewitzky S, Rennich JS, Parker A, DuPrat L, Maruti S, Chayen S, and Glaser B. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 50: 681-685, 2001.
36. Ramji DP and Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575, 2002.
37. Rao A, Luo C, and Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747, 1997.
38. Rice T, Borecki IB, Bouchard C, and Rao DC. Commingling analysis of regional fat distribution measures: the Quebec family study. Int J Obes Relat Metab Disord 16: 831-844, 1992.
39. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, and Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97: 425-428, 1998.
40. Ridker PM, Rifai N, Rose L, Buring JE, and Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002.
41. SAGE. Statistical Analysis for Genetic Epidemiology (computer program package). Cork, Ireland: Statistical Solutions, 2002.
42. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, and Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA 290: 2945-2951, 2003.
43. Soro A, Pajukanta P, Lilja HE, Ylitalo K, Hiekkalinna T, Perola M, Cantor RM, Viikari JS, Taskinen MR, and Peltonen L. Genome scans provide evidence for low-HDL-C loci on chromosomes 8q23, 16q24.1-242, and 20q1311 in Finnish families. Am J Hum Genet 70: 1333-1340, 2002.
44. Stoffel M, Le Beau MM, Espinosa R III, Bohlander SF, Le Paslier D, Cohen D, Xiang KS, Cox NJ, Fajans SS, and Bell CI. A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene. Proc Natl Acad Sci USA 93: 3937-3941, 1996.
45. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, and Verma S. New markers of inflammation and endothelial cell activation: part I. Circulation 108: 1917-1923, 2003.
46. Vatay A, Bene L, Kovacs A, Prohaszka Z, Szalai C, Romics L, Fekete B, Karadi I, and Fust G. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 55: 247-252, 2003.
47. Verma S, Szmitko PE, and Yeh ET. C-reactive protein: structure affects function. Circulation 109: 1914-1917, 2004.
48. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M, Ratcliffe PJ, Watkins HC, and Keavney B. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 53: 1029-1034, 2002.
49. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol 38: 189-197, 2001.
50. Yudkin JS, Stehouwer CD, Emeis JJ, and Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19: 972-978, 1999.
51. Zouali H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F, and Froguel P. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 6: 1401-1408, 1997.